Kewei Yang
Papers
1
Total Citations
37
H-Index
1
About
Kewei Yang is a pioneering researcher in pharmaceutical nanotechnology, with a primary focus on liposomal drug delivery systems and high-throughput formulation screening. His most cited work, "Fast high-throughput screening of temoporfin-loaded liposomal formulations prepared by ethanol injection method" (2011, 37 citations), introduced a groundbreaking strategy that automated the ethanol-injection method for rapid liposomal formulation development. This innovation enabled the efficient preparation and screening of liposomal libraries for second-generation photosensitizers like temoporfin, significantly accelerating the optimization of drug delivery systems. Yang's contributions have advanced the field of nanomedicine by providing a scalable, reproducible approach to formulation screening, reducing time and resource costs in preclinical development. His work bridges the gap between laboratory-scale preparation and clinical translation, offering a powerful tool for researchers exploring lipid-based carriers for hydrophobic drugs. By streamlining the formulation process, Yang has enabled more systematic investigations into how lipid composition affects drug loading, stability, and therapeutic efficacy, making his methodology a valuable asset for pharmaceutical scientists aiming to develop next-generation nanotherapeutics.
Research Focus
Key Achievements
Top Papers
- 1